Generali Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.7M Buy
43,226
+24,350
+129% +$9.03M 0.3% 77
2026
Q1
$5.53M Buy
18,876
+241
+1% +$79.2K 0.12% 174
2025
Q4
$6.53M Buy
18,635
+676
+4% +$228K 0.13% 144
2025
Q3
$5.8M Sell
17,959
-4,518
-20% -$1.41M 0.12% 157
2025
Q2
$8.74M Sell
22,477
-2,790
-11% -$1.12M 0.2% 107
2025
Q1
$11M Buy
+25,267
New +$10.1M 0.27% 82

Other funds holding ELV

Generali Asset Management's ELV Position: Q2 2026 in Review

Generali Asset Management increased its Elevance Health (ELV) stake by 129% in Q2 2026, buying an estimated $9.03M and bringing the position to 43,226 shares worth $16.7M. The position accounts for 0.3% of the portfolio, ranked #77.

Generali Asset Management first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Generali Asset Management held 43,226 shares of Elevance Health worth $16.7M as of Q2 2026.
  • Generali Asset Management bought 24,350 Elevance Health shares in Q2 2026, an estimated $9.03M.
  • Elevance Health made up 0.3% of Generali Asset Management's portfolio in Q2 2026, its #77 holding.
  • Generali Asset Management first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.